Official company dossier

BioGaia AB

AI Expert

Biotechnology Companiesbiogaiagroup.comUS

AI Trust Score, Reviews & Company Verification

Ownership opportunity

Is this your company? Claim the BioGaia AB profile to verify ownership and manage company-provided details.

Independent company assessment

9.1/10A · Exceptional

27 indexed evidence signals reviewed

AI Comparison

Safe Entity83% Confidence

Based on 5 polled AI models

  • GeminiGoogle DeepMind
    Safe90%Confidence
  • GrokxAI
    Safe84%Confidence
  • DeepSeekDeepSeek
    Safe80%Confidence
  • GLMZ.ai
    Safe82%Confidence
Updated Aug 27

Key stats

Sector
Biotechnology Companies
Headquarters
US
Domain
biogaiagroup.com
Domain history
Not available
Risk tier
Low
Assessed
Aug 27, 2026
From the Brand Unclaimed

BioGaia AB hasn't claimed this profile yet

ShouldEye AI builds this page from public sources. Nothing here is approved by BioGaia AB.

  • Reply to reviews
  • Publish your brand message
  • Earn the trust seal

Claiming gives you a voice, not control of the trust score.

Free for verified company teams

About

BioGaia is a Swedish biotechnology company that develops, markets and sells probiotic products aimed at supporting gut, immune and oral health.

Headquarters
US
EyeQ
EyeQ AI Live

Full intelligence report for BioGaia AB

High confidence

BioGaia AB demonstrates strong institutional credibility through exceptional regulatory standing, a highly favorable reputation, and rigorous privacy safeguards. Legal transparency and domain integrity are comparatively modest, and customer service and review signals suggest reliable but slightly uneven consumer touchpoints. Overall, the company presents as a verified, dependable operator with robust compliance and consumer protections.

Strengths
  • Privacy policy provides detailed data categories, purposes, legal bases, retention periods, and comprehensive user rights including access, erasure, rectification, limitation, objection, withdrawal of consent, and data portability.
  • Explicit opt‑in consent for newsletters and clear consent mechanisms for marketing cookies, with granular control and default essential‑only cookies.
  • Clear contact information for privacy inquiries and reference to GDPR compliance.
Key Risks
  • Sharing of user data with third‑party marketing and analytics services (e.g., Facebook Pixel, Google Analytics, Klaviyo, Hotjar, Freshdesk, YouTube) for purposes equivalent to advertising and profiling.
  • Vague justifications for data usage related to site development and business operations.
  • Absence of explicit data‑breach notification procedures in the privacy policy.
Domain & infrastructure
Abion ABDomain registrar
—Domain age
5 assetsVerified assets
Contact & Support

Connect with BioGaia AB

Find us across the web

biogaiagroup.com
  • Instagram
  • TikTok
  • YouTube
  • Facebook
  • X
  • LinkedIn
  • Threads
  • Pinterest
  • Snapchat
  • Reddit
  • Discord

No social profiles found yet.

People Behind BioGaia AB

Public-facing leadership and ownership signals for BioGaia AB — synthesized from verified profiles and corporate disclosures where available.

T
Theresa Agnew
President and Chief Executive Officer
A
Alexander Kotsinas
Chief Financial Officer
S
Staffan Strömberg
Chief Executive Officer, Infant Bacterial Therapeutics AB
E
Eamonn Connolly
Head of Research & Development, Infant Bacterial Therapeutics AB
G
Gianfranco Grompone
Chief Scientific Officer
J
Jean Bouvain
Managing Director, BioGaia Germany & Austria